BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36576262)

  • 1. Exploring molecular docking with MM-GBSA and molecular dynamics simulation to predict potent inhibitors of cyclooxygenase (COX-2) enzyme from terpenoid-based active principles of
    Nayak A; Gadnayak A; Dash KT; Jena S; Ray A; Nayak S; Sahoo A
    J Biomol Struct Dyn; 2023 Dec; 41(20):10840-10850. PubMed ID: 36576262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Mechanistic insights into 5-lipoxygenase inhibition by active principles derived from essential oils of Curcuma species: Molecular docking, ADMET analysis and molecular dynamic simulation study.
    Gadnayak A; Dehury B; Nayak A; Jena S; Sahoo A; Panda PC; Ray A; Nayak S
    PLoS One; 2022; 17(7):e0271956. PubMed ID: 35867724
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Joshi T; Sharma P; Joshi T; Chandra S
    J Biomol Struct Dyn; 2020 Aug; 38(12):3544-3562. PubMed ID: 31524074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids.
    Taidi L; Maurady A; Britel MR
    J Biomol Struct Dyn; 2022 Feb; 40(3):1189-1204. PubMed ID: 32990169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new potential cyclooxygenase-2 inhibitors: insight from high throughput virtual screening of 18 million compounds combined with molecular dynamic simulation and quantum mechanics.
    Heidarpoor Saremi L; Ebrahimi A; Lagzian M
    J Biomol Struct Dyn; 2021 Mar; 39(5):1717-1734. PubMed ID: 32122267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
    Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
    Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches.
    Cruz JV; Giuliatti S; Alves LB; Silva RC; Ferreira EFB; Kimani NM; Silva CHTP; Souza JSN; Espejo-Román JM; Santos CBR
    J Biomol Struct Dyn; 2022 Aug; 40(12):5386-5408. PubMed ID: 33427075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Probing, Screening and Structure-Based Drug Repositioning Insights into the Identification of Potential Cox-2 Inhibitors from Selective Coxibs.
    Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
    Interdiscip Sci; 2019 Jun; 11(2):153-169. PubMed ID: 29236213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Insilico evaluation of phytocompounds from Albizia amara and Phyla nodiflora as cyclooxygenase-2 enzyme inhibitors.
    Loganathan Y; Jain M; Thiyagarajan S; Shanmuganathan S; Mariappan SK; Kizhakedathil MPJ; Saravanakumar T
    Daru; 2021 Dec; 29(2):311-320. PubMed ID: 34415547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational screening of potential anti-inflammatory leads from Jeevaneeya Rasayana plants targeting COX-2 and 5- LOX by molecular docking and dynamic simulation approaches.
    Hemavathi KN; Skariyachan S; Raju R; Keshava Prasad TS; Abhinand CS
    Comput Biol Med; 2024 Mar; 171():108164. PubMed ID: 38412690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
    Dileep KV; Remya C; Tintu I; Sadasivan C
    J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precise cuts for tailoring chromene-phenyl COX inhibitors with Ligand Designer.
    Vo HHN; Phung THT; Chung KL; Vu TY
    J Mol Graph Model; 2024 Jun; 129():108747. PubMed ID: 38447296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of key enzymes in the inflammatory pathway by hybrid molecules of terpenes and synthetic drugs: In vitro and in silico studies.
    Theoduloz C; Alzate-Morales J; Jiménez-Aspee F; Isla MI; Alberto MR; Pertino MW; Schmeda-Hirschmann G
    Chem Biol Drug Des; 2019 Mar; 93(3):290-299. PubMed ID: 30294891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro, in vivo and in silico evaluation of the anti-inflammatory potential of Hyssopus officinalis L. subsp. aristatus (Godr.) Nyman (Lamiaceae).
    Mićović T; Katanić Stanković JS; Bauer R; Nöst X; Marković Z; Milenković D; Jakovljević V; Tomović M; Bradić J; Stešević D; Stojanović D; Maksimović Z
    J Ethnopharmacol; 2022 Jul; 293():115201. PubMed ID: 35358622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of andrographolide hit analog as a potent cyclooxygenase-2 inhibitor through consensus MD-simulation, electrostatic potential energy simulation and ligand efficiency metrics.
    Jain P; Satija J; Sudandiradoss C
    Sci Rep; 2023 May; 13(1):8147. PubMed ID: 37208387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
    Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
    J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hybrid platform featuring nanomagnetic ligand fishing for discovering COX-2 selective inhibitors from aerial part of Saussurea laniceps Hand.-Mazz.
    Chen Q; Zhu L; Yip KM; Tang Y; Liu Y; Jiang T; Zhang J; Zhao Z; Yi T; Chen H
    J Ethnopharmacol; 2021 May; 271():113849. PubMed ID: 33485983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization and anti-inflammatory activity evaluation of 1,2,4-triazole and its derivatives as a potential scaffold for the synthesis of drugs against prostaglandin-endoperoxide synthase.
    Khan B; Naiyer A; Athar F; Ali S; Thakur SC
    J Biomol Struct Dyn; 2021 Feb; 39(2):457-475. PubMed ID: 31900051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, anti-inflammatory, analgesic, COX-1/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4(3H)-quinazolinones.
    Abdel-Aziz AA; Abou-Zeid LA; ElTahir KEH; Ayyad RR; El-Sayed MA; El-Azab AS
    Eur J Med Chem; 2016 Oct; 121():410-421. PubMed ID: 27318118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.